CD163 and chronic obstructive pulmonary disease: There was a positive association between sCD163 and FEV1% predicted in COPD patients (rho = 0.5, p = 0.04; Figure 1) and when COPD patients and controls were combined (rho = 0.5, p = 0.0007; Figure S1).